Cargando…
Identifying and overcoming barriers to participation of minority populations in clinical trials: Lessons learned from the VanDAAM study
Participation in cancer research trials by minority populations is imperative in reducing disparities in clinical outcomes. Even with increased awareness of the importance of minority patient inclusion in clinical research to improve cancer care and survival, significant barriers persist in accruing...
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883445/ https://www.ncbi.nlm.nih.gov/pubmed/35796421 http://dx.doi.org/10.1002/cam4.5000 |
| _version_ | 1784879509089026048 |
|---|---|
| author | Fink, Angelina K. C. DeRenzis, Amanda C. Awasthi, Shivanshu Jahan, Nawreen Johnstone, Peter A. S. Pow‐Sang, Julio Torres‐Roca, Javier Grass, Daniel Fernandez, Daniel Naghavi, Arash Tan, Susan Manley, Brandon Li, Roger Poch, Michael Yu, Alice Little, Nikki Bass, Eppie Ercole, Cesar E. Katsoulakis, Evangelia Burri, Ryan Smith, Riley Stanley, Nathanael B. Vadaparampil, Susan T. Yamoah, Kosj |
| author_facet | Fink, Angelina K. C. DeRenzis, Amanda C. Awasthi, Shivanshu Jahan, Nawreen Johnstone, Peter A. S. Pow‐Sang, Julio Torres‐Roca, Javier Grass, Daniel Fernandez, Daniel Naghavi, Arash Tan, Susan Manley, Brandon Li, Roger Poch, Michael Yu, Alice Little, Nikki Bass, Eppie Ercole, Cesar E. Katsoulakis, Evangelia Burri, Ryan Smith, Riley Stanley, Nathanael B. Vadaparampil, Susan T. Yamoah, Kosj |
| author_sort | Fink, Angelina K. C. |
| collection | PubMed |
| description | Participation in cancer research trials by minority populations is imperative in reducing disparities in clinical outcomes. Even with increased awareness of the importance of minority patient inclusion in clinical research to improve cancer care and survival, significant barriers persist in accruing and retaining minority patients into clinical trials. This study sought to identify and address barriers to minority accrual to a minimal risk clinical research study in real‐time. |
| format | Online Article Text |
| id | pubmed-9883445 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98834452023-01-31 Identifying and overcoming barriers to participation of minority populations in clinical trials: Lessons learned from the VanDAAM study Fink, Angelina K. C. DeRenzis, Amanda C. Awasthi, Shivanshu Jahan, Nawreen Johnstone, Peter A. S. Pow‐Sang, Julio Torres‐Roca, Javier Grass, Daniel Fernandez, Daniel Naghavi, Arash Tan, Susan Manley, Brandon Li, Roger Poch, Michael Yu, Alice Little, Nikki Bass, Eppie Ercole, Cesar E. Katsoulakis, Evangelia Burri, Ryan Smith, Riley Stanley, Nathanael B. Vadaparampil, Susan T. Yamoah, Kosj Cancer Med RESEARCH ARTICLES Participation in cancer research trials by minority populations is imperative in reducing disparities in clinical outcomes. Even with increased awareness of the importance of minority patient inclusion in clinical research to improve cancer care and survival, significant barriers persist in accruing and retaining minority patients into clinical trials. This study sought to identify and address barriers to minority accrual to a minimal risk clinical research study in real‐time. John Wiley and Sons Inc. 2022-07-07 /pmc/articles/PMC9883445/ /pubmed/35796421 http://dx.doi.org/10.1002/cam4.5000 Text en © 2022 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | RESEARCH ARTICLES Fink, Angelina K. C. DeRenzis, Amanda C. Awasthi, Shivanshu Jahan, Nawreen Johnstone, Peter A. S. Pow‐Sang, Julio Torres‐Roca, Javier Grass, Daniel Fernandez, Daniel Naghavi, Arash Tan, Susan Manley, Brandon Li, Roger Poch, Michael Yu, Alice Little, Nikki Bass, Eppie Ercole, Cesar E. Katsoulakis, Evangelia Burri, Ryan Smith, Riley Stanley, Nathanael B. Vadaparampil, Susan T. Yamoah, Kosj Identifying and overcoming barriers to participation of minority populations in clinical trials: Lessons learned from the VanDAAM study |
| title | Identifying and overcoming barriers to participation of minority populations in clinical trials: Lessons learned from the VanDAAM study |
| title_full | Identifying and overcoming barriers to participation of minority populations in clinical trials: Lessons learned from the VanDAAM study |
| title_fullStr | Identifying and overcoming barriers to participation of minority populations in clinical trials: Lessons learned from the VanDAAM study |
| title_full_unstemmed | Identifying and overcoming barriers to participation of minority populations in clinical trials: Lessons learned from the VanDAAM study |
| title_short | Identifying and overcoming barriers to participation of minority populations in clinical trials: Lessons learned from the VanDAAM study |
| title_sort | identifying and overcoming barriers to participation of minority populations in clinical trials: lessons learned from the vandaam study |
| topic | RESEARCH ARTICLES |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883445/ https://www.ncbi.nlm.nih.gov/pubmed/35796421 http://dx.doi.org/10.1002/cam4.5000 |
| work_keys_str_mv | AT finkangelinakc identifyingandovercomingbarrierstoparticipationofminoritypopulationsinclinicaltrialslessonslearnedfromthevandaamstudy AT derenzisamandac identifyingandovercomingbarrierstoparticipationofminoritypopulationsinclinicaltrialslessonslearnedfromthevandaamstudy AT awasthishivanshu identifyingandovercomingbarrierstoparticipationofminoritypopulationsinclinicaltrialslessonslearnedfromthevandaamstudy AT jahannawreen identifyingandovercomingbarrierstoparticipationofminoritypopulationsinclinicaltrialslessonslearnedfromthevandaamstudy AT johnstonepeteras identifyingandovercomingbarrierstoparticipationofminoritypopulationsinclinicaltrialslessonslearnedfromthevandaamstudy AT powsangjulio identifyingandovercomingbarrierstoparticipationofminoritypopulationsinclinicaltrialslessonslearnedfromthevandaamstudy AT torresrocajavier identifyingandovercomingbarrierstoparticipationofminoritypopulationsinclinicaltrialslessonslearnedfromthevandaamstudy AT grassdaniel identifyingandovercomingbarrierstoparticipationofminoritypopulationsinclinicaltrialslessonslearnedfromthevandaamstudy AT fernandezdaniel identifyingandovercomingbarrierstoparticipationofminoritypopulationsinclinicaltrialslessonslearnedfromthevandaamstudy AT naghaviarash identifyingandovercomingbarrierstoparticipationofminoritypopulationsinclinicaltrialslessonslearnedfromthevandaamstudy AT tansusan identifyingandovercomingbarrierstoparticipationofminoritypopulationsinclinicaltrialslessonslearnedfromthevandaamstudy AT manleybrandon identifyingandovercomingbarrierstoparticipationofminoritypopulationsinclinicaltrialslessonslearnedfromthevandaamstudy AT liroger identifyingandovercomingbarrierstoparticipationofminoritypopulationsinclinicaltrialslessonslearnedfromthevandaamstudy AT pochmichael identifyingandovercomingbarrierstoparticipationofminoritypopulationsinclinicaltrialslessonslearnedfromthevandaamstudy AT yualice identifyingandovercomingbarrierstoparticipationofminoritypopulationsinclinicaltrialslessonslearnedfromthevandaamstudy AT littlenikki identifyingandovercomingbarrierstoparticipationofminoritypopulationsinclinicaltrialslessonslearnedfromthevandaamstudy AT basseppie identifyingandovercomingbarrierstoparticipationofminoritypopulationsinclinicaltrialslessonslearnedfromthevandaamstudy AT ercolecesare identifyingandovercomingbarrierstoparticipationofminoritypopulationsinclinicaltrialslessonslearnedfromthevandaamstudy AT katsoulakisevangelia identifyingandovercomingbarrierstoparticipationofminoritypopulationsinclinicaltrialslessonslearnedfromthevandaamstudy AT burriryan identifyingandovercomingbarrierstoparticipationofminoritypopulationsinclinicaltrialslessonslearnedfromthevandaamstudy AT smithriley identifyingandovercomingbarrierstoparticipationofminoritypopulationsinclinicaltrialslessonslearnedfromthevandaamstudy AT stanleynathanaelb identifyingandovercomingbarrierstoparticipationofminoritypopulationsinclinicaltrialslessonslearnedfromthevandaamstudy AT vadaparampilsusant identifyingandovercomingbarrierstoparticipationofminoritypopulationsinclinicaltrialslessonslearnedfromthevandaamstudy AT yamoahkosj identifyingandovercomingbarrierstoparticipationofminoritypopulationsinclinicaltrialslessonslearnedfromthevandaamstudy |